Scarica l'app Stockscreener
90.70
0.30%
-0.27
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$90.97
Aprire:
$90.6
Volume 24 ore:
5.96M
Relative Volume:
0.87
Capitalizzazione di mercato:
$116.34B
Reddito:
$34.20B
Utile/perdita netta:
$4.69B
Rapporto P/E:
25.04
EPS:
3.6218
Flusso di cassa netto:
$5.30B
1 W Prestazione:
-3.17%
1M Prestazione:
-4.77%
6M Prestazione:
+7.01%
1 anno Prestazione:
+1.62%
Intervallo 1D:
$90.09
$91.32
Intervallo di 1 settimana:
$90.09
$94.59
Portata 52W:
$79.29
$99.37
Medtronic Plc Stock (MDT) Company Profile
Nome
Medtronic Plc
Settore
Industria
Telefono
01135314381700
Indirizzo
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Confronta MDT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.78B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.69B | 1.41B | 577.90M | 6.9828 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-30 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-03-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-10-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Reiterato | Oppenheimer | Perform |
| 2024-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2024-08-14 | Downgrade | Stifel | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Sell |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Downgrade | UBS | Buy → Sell |
| 2023-01-09 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Downgrade | Citigroup | Buy → Neutral |
| 2022-11-23 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-08-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Iniziato | Wolfe Research | Underperform |
| 2022-06-01 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-06-10 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-12-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Aggiornamento | Stifel | Hold → Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-05-14 | Downgrade | DZ Bank | Buy → Hold |
| 2020-03-30 | Downgrade | Needham | Strong Buy → Buy |
| 2020-03-25 | Aggiornamento | DZ Bank | Hold → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Sell |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-02 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-06-05 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Reiterato | Needham | Strong Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-12-19 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-27 | Reiterato | Argus | Buy |
Mostra tutto
Medtronic Plc Borsa (MDT) Ultime notizie
Weak Financial Prospects Seem To Be Dragging Down Medtronic plc (NYSE:MDT) Stock - Yahoo Finance
Simon Quick Advisors LLC Has $5.25 Million Stake in Medtronic PLC $MDT - MarketBeat
Strs Ohio Lowers Position in Medtronic PLC $MDT - MarketBeat
Noesis Capital Mangement Corp Acquires 9,405 Shares of Medtronic PLC $MDT - MarketBeat
What downside risks could hit Medtronic plc (2M6) stockBear Alert & Low Drawdown Momentum Ideas - newser.com
Is Medtronic plc stock a safe haven asset2025 Technical Overview & Technical Buy Zone Confirmation - newser.com
Is Medtronic plc (2M6) stock nearing a technical breakoutJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com
What high frequency data says about Medtronic plcJuly 2025 Closing Moves & Fast Exit/Entry Strategy Plans - newser.com
Why Medtronic plc. Ordinary Shares stock could be next leaderExit Point & Entry Point Confirmation Signals - newser.com
Is Medtronic plc reversing from oversold territory2025 Market Sentiment & Stepwise Entry/Exit Trade Alerts - newser.com
Will Medtronic plc. Ordinary Shares stock outperform value peers2025 Market Overview & Expert Curated Trade Ideas - newser.com
Medtronic plc (MDT) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Global Cardiac Monitoring Devices Market to Cross USD 30 Billion by 2032, Driven by Telehealth and Remote Monitoring Trends | DelveInsight - GlobeNewswire Inc.
Detecting support and resistance levels for Medtronic plcJuly 2025 Macro Moves & Daily Growth Stock Investment Tips - newser.com
World Investment Advisors Has $13.61 Million Position in Medtronic PLC $MDT - MarketBeat
Econ Financial Services Corp Invests $2.16 Million in Medtronic PLC $MDT - MarketBeat
Eubel Brady & Suttman Asset Management Inc. Raises Stock Holdings in Medtronic PLC $MDT - MarketBeat
Can Medtronic plc (2M6) stock double in coming years2025 Volatility Report & Verified Entry Point Signals - newser.com
Medtronic (MDT) Stock Moves -1.61%: What You Should Know - sharewise.com
Medtronic PLC stock underperforms Wednesday when compared to competitors - MarketWatch
CMS grants NCD for renal denervation, benefiting Medtronic, Recor - MedTech Dive
December 2026 Options Now Available For Medtronic (MDT) - Nasdaq
Mizuho Markets Cayman LP Acquires Shares of 207,547 Medtronic PLC $MDT - MarketBeat
Mizuho Markets Americas LLC Trims Stock Holdings in Medtronic PLC $MDT - MarketBeat
New York Life Investment Management LLC Purchases 3,445 Shares of Medtronic PLC $MDT - MarketBeat
GWN Securities Inc. Has $560,000 Stock Holdings in Medtronic PLC $MDT - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Boosts Position in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Sold by Brighton Jones LLC - MarketBeat
CMS finalizes renal denervation coverage that benefits Medtronic, Recor - MassDevice
MEDTRONIC PLC CEDEAR EACH 4 REP (MDT.BA) Q1 FY2025 earnings call transcript - Yahoo Finance
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral renal denervation system - Investing News Network
Medtronic (MDT) Gains CMS Approval for Innovative Blood Pressure Treatment - GuruFocus
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system - The Malaysian Reserve
Medtronic (NYSE: MDT) receives CMS NCD coverage for Symplicity Spyral renal denervation - Stock Titan
Medtronic Launches Stedi Extra Support Guidewire to Enhance TAVR System Performance - Diagnostic and Interventional Cardiology
Will Medtronic’s RDN study drive Spyral-ing growth? - BioWorld MedTech
Medtronic Plc Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Medtronic links renal denervation to 3-year blood pressure reduction - MedTech Dive
Medtronic PLC $MDT Position Boosted by Tevis Investment Management - MarketBeat
Motley Fool Wealth Management LLC Has $5.15 Million Stock Position in Medtronic PLC $MDT - MarketBeat
IQ EQ FUND MANAGEMENT IRELAND Ltd Increases Stock Position in Medtronic PLC $MDT - MarketBeat
Is Medtronic plc (2M6) stock cheap by valuation metrics2025 Trade Ideas & Smart Swing Trading Techniques - newser.com
Medtronic PLC $MDT Shares Sold by Wealthfront Advisers LLC - MarketBeat
Medtronic PLC $MDT Stake Boosted by Bessemer Group Inc. - MarketBeat
Is Medtronic plc (2M6) stock expanding market penetrationEarnings Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
How Medtronic plc (2M6) stock behaves under inflation pressureQuarterly Portfolio Review & Free AI Powered Buy and Sell Recommendations - Fundação Cultural do Pará
How to interpret RSI for Medtronic plc stockLayoff News & Growth Focused Stock Reports - newser.com
Medtronic shares first results from new Symplicity Spyral RDN study - MassDevice
Will Medtronic plc. Ordinary Shares stock hit Wall Street targetsJuly 2025 Technicals & Expert-Curated Trade Recommendations - Fundação Cultural do Pará
Medtronic Plc Azioni (MDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.45%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):